Patents by Inventor Robert A. Armstrong

Robert A. Armstrong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6716960
    Abstract: The invention provides an isolated gene encoding Mch3, or functional fragment thereof. Also provided is an isolated nucleic acid sequence encoding Mch3 or functional fragment thereof. The gene or nucleic acid sequence can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch3 nucleotide sequence. An isolated Mch3 polypeptide or functional fragment thereof is also provided.
    Type: Grant
    Filed: January 2, 2003
    Date of Patent: April 6, 2004
    Assignees: Idun Pharmaceuticals, Inc., Thomas Jefferson University
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Publication number: 20040054148
    Abstract: The invention provides an isolated gene encoding Mch4 or an isolated gene encoding Mch5 as well as functional fragments thereof. Also provided are isolated nucleic acid sequences encoding Mch4 or Mch5 or functional fragment thereof. The gene or nucleic acid sequences can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch4 or Mch5 nucleotide sequences. Also provided are genes and nucleic acids encoding functional fragments such as the FADD-like domains Mch4A, Mch4B, Mch5A and Mch5B. Isolated Mch4 or Mch5 polypeptides or functional fragments thereof including the FADD-like domains Mch4A, Mch4B, Mch5A and Mch5B are also provided.
    Type: Application
    Filed: September 22, 2003
    Publication date: March 18, 2004
    Applicants: Thomas Jefferson University, IDUN Pharmaceuticals
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Patent number: 6686459
    Abstract: The invention provides an isolated gene encoding Mch3, or functional fragment thereof. Also provided is an isolated nucleic acid sequence encoding Mch3 or functional fragment thereof. The gene or nucleic acid sequence can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch3 nucleotide sequence. An isolated Mch3 polypeptide or functional fragment thereof is also provided.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: February 3, 2004
    Assignees: IDUN Pharmaceuticals, Inc., Thomas Jefferson University
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Publication number: 20030119169
    Abstract: The invention provides an isolated gene encoding Mch3, or functional fragment thereof. Also provided is an isolated nucleic acid sequence encoding Mch3 or functional fragment thereof. The gene or nucleic acid sequence can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch3 nucleotide sequence. An isolated Mch3 polypeptide or functional fragment thereof is also provided.
    Type: Application
    Filed: January 2, 2003
    Publication date: June 26, 2003
    Applicant: IDUN Pharmaceuticals, Inc.
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Publication number: 20030099206
    Abstract: A method and arrangement for automatic frequency correction in UTRA TDD mode, having a first stage (500) for frequency lock in idle mode, and a second stage (600) for receiving a channel estimate from beacon function (mx1), receiving a channel estimate from at least one other physical channel (mx2), and receiving output from a primary synchronisation code correlator (mx0, pc1, pc2), and for producing therefrom signals (X,Y,N) for use in frequency correction. By utilising first and second partial correlation values (pc1, pc2) which are balanced, DC offset effects may be substantially removed. This provides the following advantage of significantly improving performance at low levels of SNR, and removal of DC offset effects provides immunity to DC offsets arising from imperfections in hardware.
    Type: Application
    Filed: September 12, 2002
    Publication date: May 29, 2003
    Applicant: IP WIRELESS, INC.
    Inventors: Alan Edward Jones, Paul Howard, Robert Armstrong
  • Publication number: 20020160238
    Abstract: A method for converting fuel energy to electricity includes the steps of converting a higher molecular weight gas into at least one lower molecular weight gas, supplying at least one of the lower molecular weight gases to at least one turbine to produce electricity and electrochemically oxidizing at least one of the lower molecular weight gases in fuel cells. A system for converting fuel energy to electricity includes a reformer for converting a higher molecular weight gas into at least one lower molecular weight gas, at least one turbine to produce electricity from expansion of at least one of the lower molecular weight gases, and at least one fuel cell. The system can further include at least one separation device for substantially dividing the lower molecular weight gases into at least two gas streams prior to the electrochemical oxidization step. A nuclear reactor can be used to supply at least a portion of the heat the required for the chemical conversion process.
    Type: Application
    Filed: March 21, 2001
    Publication date: October 31, 2002
    Inventors: Solomon Davidovich Labinov, Timothy Robert Armstrong, Roddie Reagan Judkins
  • Patent number: 6462175
    Abstract: The invention provides an isolated gene encoding Mch3, or functional fragment thereof. Also provided is an isolated nucleic acid sequence encoding Mch3 or functional fragment thereof. The gene or nucleic acid sequence can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch3 nucleotide sequence. An isolated Mch3 polypeptide or functional fragment thereof is also provided.
    Type: Grant
    Filed: November 13, 1995
    Date of Patent: October 8, 2002
    Assignees: Thomas Jefferson University, Idun Pharmaceuticals, Inc.
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Publication number: 20020102648
    Abstract: The invention provides an isolated gene encoding Mch3, or functional fragment thereof. Also provided is an isolated nucleic acid sequence encoding Mch3 or functional fragment thereof. The gene or nucleic acid sequence can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch3 nucleotide sequence. An isolated Mch3 polypeptide or functional fragment thereof is also provided.
    Type: Application
    Filed: August 31, 2001
    Publication date: August 1, 2002
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Patent number: 6385220
    Abstract: A laser clamping system for a disc laser medium that includes two heat conductive members (one of which is optically transparent) positioned on either side of a disc laser. Pressure is applied to the conductive members to restrain the disc from deforming under pumping conditions to reduce the lensing effect. Thin disc geometry allows the thermal load of laser material to be much closer to the heat conductive members so that heat dissipation is generally more efficient than that of other geometric configurations (e.g. rod or slab). In disc lasers each part of the laser beam experiences the same temperature gradient so that there is no lensing effect caused by radial temperature distribution. It has been discovered that any resulting lensing effect is disc lasers is mainly from the thermo-mechanical deformation of the disc itself.
    Type: Grant
    Filed: April 21, 1999
    Date of Patent: May 7, 2002
    Assignee: GSI Lumonics Inc.
    Inventors: Robert John Dwayne Miller, Yan Liao, Michael Robert Armstrong, David Ronald Walker
  • Patent number: 6375410
    Abstract: A frangible cover is provided for a recess in a containment case for turbofan engine blade removal and access. The recess provided in the containment case allows outward radial movement of the engine fan blade when the engine fan blade is to be removed from the containment case. The present invention proposes a frangible component to cover the recess. A plurality of initiation points, notched in the frangible cover at intersections of surfaces encourages brittle fracture of the frangible component.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: April 23, 2002
    Assignee: General Electric Company
    Inventors: Brian Ellis Clouse, Robert Armstrong Morse
  • Publication number: 20020035242
    Abstract: The invention provides an isolated gene encoding Mch4 or an isolated gene encoding Mch5 as well as functional fragments thereof. Also provided are isolated nucleic acid sequences encoding Mch4 or Mch5 or functional fragment thereof. The gene or nucleic acid sequences can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch4 or Mch5 nucleotide sequences. Also provided are genes and nucleic acids encoding functional fragments such as the FADD-like domains Mch4A, Mch4B, Mch5A and Mch5B. Isolated Mch4 or Mch5 polypeptides or functional fragments thereof including the FADD-like domains Mch4A, Mch4B, Mch5A and Mch5B are also provided.
    Type: Application
    Filed: September 10, 2001
    Publication date: March 21, 2002
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Patent number: 6315792
    Abstract: The invention creates a thin tubular multiple filament (film or fiber) structure that can hold high internal pressures. When desired, an extension of the filaments can be pulled in any direction to unfurl the structure. This device is useful for self expanding stent or stent graft delivery systems, balloon dilatation catheters, removable guide wire lumens for catheters, drug infusion or suction catheters, guide wire bundling casings, removable filters, removable wire insulation, removable packaging and other applications.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: November 13, 2001
    Assignee: Gore Enterprise Holdings, Inc.
    Inventors: Joseph Robert Armstrong, Michael Vonesh
  • Publication number: 20010031198
    Abstract: A frangible cover is provided for a recess in a containment case for turbofan engine blade removal and access. The recess provided in the containment case allows outward radial movement of the engine fan blade when the engine fan blade is to be removed from the containment case. The present invention proposes a frangible component to cover the recess. A plurality of initiation points, notched in the frangible cover at intersections of surfaces encourages brittle fracture of the frangible component.
    Type: Application
    Filed: January 12, 2001
    Publication date: October 18, 2001
    Inventors: Brian Ellis Clouse, Robert Armstrong Morse
  • Patent number: 6287795
    Abstract: The invention provides an isolated gene encoding Mch4 or an isolated gene encoding Mch5 as well as functional fragments thereof. Also provided are isolated nucleic acid sequences encoding Mch4 or Mch5 or functional fragment thereof The gene or nucleic acid sequences can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch4 or Mch5 nucleotide sequences. Also provided are genes and nucleic acids encoding functional fragments such as the FADD-like domains Mch4A, Mch4B, Mch5A and Mch5B. Isolated Mch4 or Mch5 polypeptides or functional fragments thereof including the FADD-like domains Mch4A, Mch4B, Mch5A and Mch5B are also provided.
    Type: Grant
    Filed: April 13, 1999
    Date of Patent: September 11, 2001
    Assignees: Thomas Jefferson University, IDUN Pharmaceuticals, Inc.
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Patent number: 6224627
    Abstract: The invention creates a thin tubular multiple filament (film or fiber) structure that can hold high internal pressures. When desired, an extension of the filaments can be pulled in any direction to unfurl the structure. This device is useful for self expanding stent or stent graft delivery systems, balloon dilatation catheters, removable guide wire lumens for catheters, drug infusion or suction catheters, guide wire bundling casings, removable filters, removable wire insulation, removable packaging and other applications.
    Type: Grant
    Filed: June 15, 1998
    Date of Patent: May 1, 2001
    Assignee: Gore Enterprise Holdings, Inc.
    Inventors: Joseph Robert Armstrong, Michael Vonesh
  • Patent number: 6214493
    Abstract: A novel layered material for use in electrochemical cells is provided, together with a method for producing the layered material, and a cell having the layered material as the positive electrode. The material is of the form QqMnyMzO2, where Q and M are each any element, y is any number greater than zero, and q and z are each any number greater than or equal to zero, and the material has a layered structure. Methods of preparing the manganese oxide material are provided, using an ion exchange reaction or an ion removal reaction. Use of the material in an electrochemical cell is demonstrated.
    Type: Grant
    Filed: August 9, 1999
    Date of Patent: April 10, 2001
    Assignee: The University Court of the University of St. Andrews
    Inventors: Peter George Bruce, Anthony Robert Armstrong
  • Patent number: 5851815
    Abstract: The invention provides an isolated gene encoding Mch4 or an isolated gene encoding Mch5 as well as functional fragments thereof. Also provided are isolated nucleic acid sequences encoding Mch4 or Mch5 or functional fragment thereof. The gene or nucleic acid sequences can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch4 or Mch5 nucleotide sequences. Isolated Mch4 or Mch5 polypeptides or functional fragments thereof are also provided.
    Type: Grant
    Filed: March 19, 1996
    Date of Patent: December 22, 1998
    Assignee: IDUN Pharmaceuticals, Inc.
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Patent number: 5786173
    Abstract: The invention provides an isolated gene encoding Mch4 or an isolated gene encoding Mch5 as well as functional fragments thereof. Also provided are isolated nucleic acid sequences encoding Mch4 or Mch5 or functional fragment thereof. The gene or nucleic acid sequences can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch4 or Mch5 nucleotide sequences. Also provided are genes and nucleic acids encoding functional fragments such as the FADD-like domains Mch4A, Mch4B, Mch5A and Mch5B. Isolated Mch4 or Mch5 polypeptides or functional fragments thereof including the FADD-like domains Mch4A, Mch4B, Mch5A and Mch5B are also provided.
    Type: Grant
    Filed: June 14, 1996
    Date of Patent: July 28, 1998
    Assignee: Idun Pharmaceuticals, Inc.
    Inventors: Emad S. Alnemri, Teresa Fernandes-Alnemri, Gerald Litwack, Robert Armstrong, Kevin Tomaselli
  • Patent number: 5398827
    Abstract: A multi-vesselled beverage container including at least two elongated vessels or tubes which are connected in an adjacent relationship relative to each other. Each tube has an open top portion and a closed bottom portion such that each tube can hold a beverage therein. The tubes are connected such that the top portions of the tubes are disposed in generally coplanar relation relative to each other. The cross-sectional configuration of the tubes are specifically sized toward the top portions thereof to define a cumulative width between opposite sides of the tubes to facilitate simultaneous and direct pouring of the beverages from the tubes into a person's mouth whereat the beverages commingle with each other to provide a taste sensation different than that provided by either individual beverage.
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: March 21, 1995
    Assignee: Flair Communications Agency, Inc.
    Inventors: Robert Armstrong, Susan E. Johnson, Maryann Bott
  • Patent number: D356232
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: March 14, 1995
    Assignee: Flair Communications Agency, Inc.
    Inventors: Robert Armstrong, Susan E. Johnson, Maryann Bott